Genitourinary videos

Round-ups, expert picks and interviews, newest first.

October 2025

  1. Day 4 round-up: IMvigor011, DYNAMIC-III, FORTITUDE-101

    Dr. Gil Morgan. Daily round-up. Day 4. October 21, 2025.

  2. Day 3 round-up: the top five trials

    Dr. Gil Morgan. Daily round-up. Day 3. October 21, 2025.

  3. Day 2 round-up: five practice-changing trials

    Dr. Gil Morgan. Daily round-up. Day 2. October 21, 2025.

  4. Prostate cancer: EMBARK, CAPItello-281, PETRANHA

    Dr. Gil Morgan. Expert pick. October 21, 2025.

  5. Radioligand therapy in prostate cancer

    Dr. Silke Gillessen. Interview. October 21, 2025.

  6. Kidney cancer: RAMPART, O3A and OPTIC

    Dr. Brian Rini. Expert pick. October 21, 2025.

  7. OPTIC RCC: a biomarker-selected combination

    Dr. Brian Rini. Expert pick. October 21, 2025.

  8. DISCUS (LBA 109): three or six cycles before avelumab

    Dr. Enrique Grande. Expert pick. October 21, 2025.

  9. IMvigor011: ctDNA after cystectomy

    Dr. Tom Powles. Expert pick. October 21, 2025.

June 2025

  1. Prostate cancer at ASCO 2025

    Dr. Natalia Gandur. Expert pick. June 3, 2025. In Spanish.

  2. CBM588 with nivolumab and ipilimumab in kidney cancer

    Dr. Miguel Zugman. Interview. June 3, 2025.

  3. CheckMate 214: the nine-year final results

    Dr. Brian Rini. Interview. June 3, 2025.

  4. Metastatic castration-resistant prostate cancer at ASCO 2025

    Dr. Natalia Gandur. Expert pick. June 3, 2025. In Spanish.

  5. KIM-1 in renal cell carcinoma

    Dr. Marc Machaalani. Interview. June 3, 2025.

  6. Bladder cancer: antibody-drug conjugates, today and tomorrow

    Dr. Brian Rini. Interview. June 3, 2025.